Accordingly, further mechanistic investigations showed that LINC00494 recruited transcription factor NFκB1 to bind on the promoter region of FBXO32, which inhibited the transcription of FBXO32, while suppressing the progression and development of ovarian cancer. The gene discussed is FBXO32; the disease is ovarian carcinoma.